在MRSA分离物中有效地根除生物膜,其中含有氨基糖化物修饰酶基因,使用高度和长时间的 gentamicin 治疗
Kohei Ando1, Satoshi Miyahara2, Shuhei Hanada2,3
1Department of Emergency and Intensive Care Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Microbiology spectrum
|August 27, 2024
概括
高度的 جنت米辛有效地根除了耐甲氨酸的金黄色葡萄球菌 (MRSA) 生物膜. 健美素抗性基因,特别是 aac(6') -aph(2"),可以预测骨科生物膜感染的治疗易感性.
科学领域:
- 整形外科 整形外科 整形外科
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 由MRSA等生物膜形成细菌引起的骨和软组织感染具有挑战性.
- 目前的治疗方法包括局部抗生素和局部 perfusion 治疗,但最佳策略尚不清楚.
- 消除生物膜对于成功管理这些感染至关重要.
研究的目的:
- 为了评估高度 gentamicin 对MRSA生物膜的疗效.
- 研究 gentamicin 耐药基因在生物膜根除中的作用.
- 确定在骨科MRSA生物膜感染中选择治疗的潜在预测标志物.
主要方法:
- 对来自日本一家医院的101个MRSA临床分离物的分析.
- 评估甲西林和 gentamicin 的耐药性概况.
- 确定最小生物膜消除度 (MBEC) 值.
- 鉴定和关联的氨基糖化物/丁胺素耐药性基因与丁胺素敏感性.
主要成果:
- 高度的 جنت米辛在抗 MRSA 生物膜方面显示出有效性.
- 长时间暴露于低于MBEC的 جنت胺度可能会消除生物膜.
- 鉴定出了三种抗珍塔米辛的基因[aac(6"> -aph(2 ′′), aph(3"> -III, ant(4"> -IA].
- aac(6"> -aph(2′′) 基因与珍塔米辛最小抑制度 (MIC) 和MBEC值相关.
结论:
- 高度,延长的局部 gentamicin 治疗可以有效地消除骨科感染中的 MRSA 生物膜.
- 检测 جنت米辛MIC或aac(6"> -aph(2′′) 基因的存在可以帮助选择合适的治疗方法.
- 这项研究为优化针对MRSA生物膜的基因胺基基策略提供了洞察力.
相关概念视频
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


